Back
Speaker illustration

Doctor Kei Yoshioka

Kansai Medical University Medical Center, Osaka (Japan)

Presentations

Impact of early tolvaptan treatment for very elderly patients with heart failure and chronic kidney disease

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Diuretics

Session: Chronic heart failure

Access
Like
Thumbnail

Tolvaptan is useful and safe for the treatment of very elderly patients with heart failure and chronic kidney disease

Event: HEART FAILURE 2016

Topic: Chronic nursing care

Session: Chronic heart failure

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources